Declining global male fertility rates has generated increased attention on male fertility in recent years. Simultaneously, individualised responsibility for health has been growing. Fertility and lifestyle have therefore become seemingly intertwined. Esmee Sinead Hanna and Brendan Gough examine men's experiences of fertility and lifestyle practices, exploring personal experiences of the role of lifestyle in the quest for conception as well as the broader promotion of 'lifestyle' within both clinical and online material as a key aspect for 'improving' male fertility. Through the exploration of male fertility and lifestyle factors and their modification we examine the growth of healthism around infertility, the role of neoliberalism within this and how this intersects with masculinity. Using a new notion of liquid masculinity, we explore the fluid nature of societal and personal perspectives on the male infertility experience. In doing so we offer new insights into the now accepted idea that 'sperm' is malleable and that fertility controllable through personal choices, despite their being limited scientific evidence for such claims.

For the generation that reached sexual maturity in the 1960s, the "pill" became synonymous with sexual freedom and started a sexual revolution. For women it meant freedom from the fear of pregnancy, and for men enhanced sexual opportunity. The new era of the pill has nothing to do with fertility, but everything to do with sex. The first orally effective prescr- tion drug for treating erectile dysfunction (ED) was marketed in 1998. (R) Sildenafil (Viagra ) has rejuvenated the aging male veterans of the sexual revolution, forever changed the science of sexual medicine, and tra- formed society's perspective on aging and sex. This class of drugs, known as oral phosphodiesterase inhibitors (PDE-type 5), is highly effective in the treatment of ED. Since its introduction there has been a much greater awa- ness of ED, its comorbidities, and its effects on the quality of life. In 1997, while preparing to address the Endocrine Society on the occasion of the 92nd American Urological Association meeting, I first looked at the p- clinical studies of sildenafil. I thought "this will change everything" and it clearly has-changing practice patterns in sexual medicine, and the at- tudes of patients, potential patients, and their partners. Two new PDE-type (R) (R) 5 inhibitors, tadalafil (Cialis ) and vardenafil (Levitra ), were first approved by the European Committee for Proprietary Medicinal Products and subsequently by the Food and Drug Administration in 2003 and 2004.

Among the many recent advances in assisted reproduction therapies (ART), improved technologies for identifying viable oocytes, sperm, and embryos are of primary importance. Paradoxically, the latest advances presented at conferences and symposia are often slow to become part of the daily routine in IVF laboratories. Detailing established and developing techniques, A Practical Guide to Selecting Gametes and Embryos provides a user-friendly text of ready-to-use ARTs that can be utilized effectively in the lab.

In this volume, renowned embryologist and educator Markus Montag and his expert panel highlight sophisticated and proven selection strategies and emphasize the importance of proper lab practice in handling gametes and embryos.

Topics include:

• Steps undertaken for the analysis of a semen sample
• Quality control and prevention of exposure to toxins in oocyte collection and embryo culture
• Morphological selection of gametes and embryos
• Both commonly used and innovative techniques for gamete and embryo selection, such as oxygen respiration and time-lapse imaging
• Invasive techniques, including polar body, embryo, and blastocyst biopsies as well as aneuploidy testing by FISH and array-CGH

Accompanied by numerous figures and descriptions, this guide to selecting gametes and embryos brings the insight of international authors with knowledge and expertise, highlighting practical tips and key points. The book offers a starting point for applying successful selection strategies for reducing the rate of high-risk multiple gestations while maintaining or increasing viable pregnancy rates.

Welcomed as liberation and dismissed as exploitation, egg freezing (oocyte cryopreservation) has rapidly become one of the most widely-discussed and influential new reproductive technologies of this century. In Freezing Fertility, Lucy van de Wiel takes us inside the world of fertility preservation—with its egg freezing parties, contested age limits, proactive anticipations and equity investments—and shows how the popularization of egg freezing has profound consequences for the way in which female fertility and reproductive aging are understood, commercialized and politicized. Beyond an individual reproductive choice for people who may want to have children later in life, Freezing Fertility explores how the rise of egg freezing also reveals broader cultural, political and economic negotiations about reproductive politics, gender inequities, age normativities and the financialization of healthcare. Van de Wiel investigates these issues by analyzing a wide range of sources—varying from sparkly online platforms to heart-breaking court cases and intimate autobiographical accounts—that are emblematic of each stage of the egg freezing procedure. By following the egg’s journey, Freezing Fertility examines how contemporary egg freezing practices both reflect broader social, regulatory and economic power asymmetries and repoliticize fertility and aging in ways that affect the public at large. In doing so, the book explores how the possibility of egg freezing shifts our relation to the beginning and end of life.

The successful achievement of pregnancies following pre-implantation genetic diagnosis (PGD) was first reported in April 1990. The technology is often used for patients who are at substantial risk of conceiving a pregnancy affected by a known genetic disorder, however from this technology other more controversial uses have arisen such as HLA typing to save the life of a sibling, gender selection for social reasons, the prevention of late onset diseases, or the prevention of diseases which may be genetically predisposed to developing such as breast cancer. The technology surrounding PGD is constantly developing, giving rise to new and unexpected consequences that create fresh ethical and legal dilemmas. Featuring internationally recognized experts in the field, this book critically explores the regulation of PGD and the broader legal and ethical issues associated with it. It looks at the regulatory situation in a number of jurisdictions including New Zealand, Australia and the United Kingdom, but it also explores a number of themes of wide significance including a historical consideration of PGD and its part in the creation of the "genetic embryo" as a political tool, the over regulation of PGD and the ethical difficulties in handling additional unexpected medical information yielded by new technologies. This book will be of particular interest to academics and students of law, medicine and ethics.

In Reproductive Medicine and the Life Sciences in the Contemporary Economy, Alexander Styhre and Rebecka Arman illuminate issues that have given rise to terms such as 'the bioeconomy' and 'the baby business'. The life sciences play an increasing role in providing services and commodities consumed by businesses and the public. Based on an in-depth study of clinics offering assisted fertilization in Sweden, this book is the first to examine the commercialization and commodification of know-how derived from the life sciences, from the point of view of organization theory. In the field of reproductive medicine there has been significant growth of both public and private clinical work. Clinics are places where individual interests and concerns and social and institutional arrangements intersect. With a front office where patients encounter various professional groups and a back office comprising the laboratories wherein human reproductive materials are handled and stored, they are more than just places in which medicine is applied in a clinical setting. Clinicians in this field actively influence policy-making and the regulatory frameworks that monitor and set the boundaries for their work. These are places where social and cultural interests and concerns are translated into policies and practice. The clinics are open social systems, responding to and influencing discussions. This book combines organization theory, sociological theory, gender theory, science and technology studies, and philosophy. It emphasises the critical importance of a sociomaterial perspective on organization, stressing how material and social resources are always of necessity folded into each other in day-to-day organizing.

Today, we are exposed to an increasing number of chemicals in the environment and there is a growing awareness of the effects of these chemicals on the ovaries. Infertility resulting from environmental exposures may not be obvious until the reproductive life span is waning. As such, the potential for xenobiotic-induced infertility needs to be better understood. In recent years, research into chemicals that have the potential to cause early menopause by destroying pre-antral ovarian follicles is gaining greater appreciation. Ovarian Toxicology, Second Edition represents a compilation of chapters prepared by researchers who have substantially contributed to our understanding of the impact of xenobiotics and environmental factors on ovarian function. The second edition substantially updates newly investigated ovotoxicants as well as improved mechanistic insights that have emerged since the first edition. Topics include: Ovarian physiology and the metabolism of xenobiotics The effect of pesticides, heavy metals, phthalates, BPA, and cigarette smoking on the ovaries Ovarian cancer, including endocrine effects and new perspectives on chemoresistance Epidemiology and human health risk assessment for environmental chemicals and pharmaceuticals The first book to focus specifically on ovarian toxicology, this resource is ideal for scientists in academia, regulatory agencies, and industry who would benefit from a survey of the impact of xenobiotic chemicals on ovarian function.

Bringing together the latest information on the organization, management and quality of in-vitro fertilization (IVF) units, this is the first true field guide for the clinician working in assisted reproductive technologies (ART). Divided thematically into four main sections, part one discussed the establishment and organization of the IVF unit, including location, design and construction, practical considerations for batching IVF cycles, and regulations and risk management. Part two, the largest section, covers the many aspects of overall quality management and its implementation - staff and patient management, cryobank and PGD/PGS management, and data management - as well as optimization of treatment outcomes and statistical process control analysis to assess quality variation. Part three addresses the relationship between IVF units and society at large, including the ethics of IVF treatment, as well as public/low-cost and private/corporate IVF units. Advertising and marketing for IVF units is discussed in part four, including the building and managing of websites and the use of traditional print and social media. With approximately five thousand IVF units worldwide and a growing number of training programs, Organization and Management of IVF Units is a key resource for clinic directors, unit managers, embryologists, quality experts, and students of reproductive medicine and clinical embryology.

Technologies of Sexuality, Identity and Sexual Health highlights the complex ways in which sexuality is expressed and enacted through local ideologies, global identities and material cultures, and their influence on people s sexual health and well-being. Its impetus is the renewed interest in technology and the social life of things, including pharmaceuticals, expanded sexual and related surgery, the growing exploitation of markets for sexual and contraceptive products, and the impact of these on sexual and health practices and outcomes.

Organised loosely into three parts, the opening chapters concentrate on female contraception, its availability, and the varied cultural significance attached to the ability to control its use, exploring the politics of reproductive health and birth control, and the ties between technology and power. The middle section turns its attention to men, and the impact of traditional and contemporary concerns about masculinity, and the social and sexual roles of men. The final chapters look at the commonalities across cultural borders and sexual gendered identities how products and procedures travel, not only through the formal channels of globalisation, but also informally, carried by individuals across cultural and social boundaries through sexual, social and commercial interactions.

The volume brings together anthropologists, sociologists and cultural studies scholars, both senior and emerging, from around the globe. Offering an important and topical contribution to the developing global literature on sexuality, sexual identity, culture and health, it is of interest to researchers and advanced students in these areas.

One in seven couples experience problems in conceiving, and this book provides information about fertility investigations, treatments, management and dilemmas. This overview of the management of couples with fertility problems is a straightforward account of best practice in the UK today. Fertility treatments have many ethical implications and the book explains the challenges we face following new developments in assisted reproduction, cloning, surrogacy and rationing. Fertility Problems helps GPs and their teams undertake as much management as possible in primary care, and enables them to understand and explain the issues to infertile patients. The book is also useful for patients themselves. Junior doctors, nurses, counsellors and members of ethics committees will find it a valuable introduction and overview. Much of the material is based on the guidelines for clinical management produced by the Royal College of Obstetricians and Gynaecologists. The author is a general practitioner and former member of the Human Fertilisation and Embryology Authority.

This new edition of an acclaimed text reviews the evidence for best practice in Maternal-Fetal Medicine, to present the reader with the right information, with appropriate use of proven interventions and avoidance of ineffectual or harmful ones. The information is presented in the right format by summarizing evidence succinctly and clearly in tables and algorithms. The aim is to inform the clinician, to reduce errors and "to make it easy to do it right." The volume can be purchased separately or together with the companion volume on Obstetric Evidence Based Guidelines (set ISBN 9780367567033). The Series in Maternal-Fetal Medicine is published in conjunction with the Journal of Maternal-Fetal and Neonatal Medicine. From reviews of previous editions: An excellent resource with quick and easy protocols... this book has a permanent spot on my shelf. -Doody's Review Service

This gold standard text has kept its readers abreast of rapid advancements in reproductive medicine and surgery since 1983. Continuing this tradition, this fifth edition has been fully updated and revised to provide clear, didactic advice on best practice for a variety of clinical situations faced by practitioners across many specialties - including urologists, gynecologists, reproductive endocrinologists, medical endocrinologists and many in internal medicine and family practice who see men with suboptimal fertility and reproductive problems. Completely restructured to include pedagogical features such as easily accessible key concepts that cement understanding and real-world use. Covering everything from foundations of anatomy and embryology, through clinical evaluation, diagnostic approaches, treatment and fertility care in context within the healthcare system and society, thrilling advances and future directions are also included. This new edition is an essential reference for all who are working in this young and rapidly evolving field.

These proceedings of the 2018 XIII International Symposium on Spermatology focus on comparative biology, and encourages discussion and the exchange of ideas. The aim of this Symposium was to provide a unique opportunity and bring together scientists from a wide spectrum of research fields - human, domestic animals and other mammals, vertebrates, insects, and plants. The underlying focus is on the function of the spermatozoon - a common feature for sexual reproduction, but extremely varied. By exploring the variability, a better understanding of male reproductive functions can develop. These proceedings address the mechanisms of physiology and pathophysiology, rather than diagnosis and treatment. The symposium featured keynote lectures by invited speakers, followed by presentations on specific aspects of the general topic of the session. Experimental studies are given priority over clinical studies of patient populations. The proceedings comprise both keynote speakers' texts and selected free communications. Posters were considered for publication in the proceedings, and the volume includes exhibited materials on the work of prominent spermatologists, highlighting their important past achievements in the field.

Stillbirth remains a sufficiently frequent outcome of pregnancy to pose great problems for clinicians, who have to treat extremely distressed patients. This concise but comprehensive book from an international team of contributors sets out clear guidelines for clinical procedures and patient management for the obstetrician, as well as the gynecologist and the gynecologic pathologist.

Providing a comprehensive review of the interactions between exercise and human reproduction, this unique text focuses on both the positive and negative consequences of sport and physical activity on male and female fertility and infertility and the biological mechanisms and processes behind them. Beginning with a review of the structure and function of the male and female reproductive systems as well as fertilization and gestation, the discussion then turns to the physiology and endocrinology of sport and exercise, which is further elaborated in subsequent chapters on the impact of physical activity, hormonal changes, pathologies, and consequences of drug use for active men and women. Additional chapters address related topics, such as the impact of sport on young athletes and developing reproductive potential, physical activity and pregnancy, the use of oral contraceptives in athletes, oxidative stress, and the impact of nutritional deficiencies on athletes' fertility, with a final chapter providing recommendations and therapeutic guidelines for exercise-related reproductive disorders. Covering everything from the fundamental principles of sports physiology and human reproductive potential to the interaction between physical exercise and the endocrinology of the reproductive system, Exercise and Human Reproduction is an authoritative resource for helping clinicians understand how the reproductive system adapts to activity and exercise and offers strategies to avoid potential harm to human reproduction.

Oocyte cryopreservation entails important potential advantages for human IVF, offering a less ethically disputable alternative to embryo cryopreservation, simplifying and making safer oocyte donation, and giving an opportunity for fertility preservation to women at risk of premature ovarian failure as an effect of genetic factors or chemo- or radiotherapies. Oocyte cryopreservation could also meet the expectations of women wishing to preserve their fertility for social reasons. In the last few years, advances in cryopreservation methodologies have dramatically improved the efficiency of oocyte cryopreservation, leading to the birth of over a thousand babies and challenging the supremacy of embryo cryopreservation as the preferred form of fertility preservation. This text has been conceived with the aim of offering a comprehensive view of the state of the art of oocyte cryopreservation. It covers fundamental concepts of low temperature storage (controlled rate slow cooling and vitrification), aspects of oocyte physiology relevant to the process of cryopreservation, essential biological and clinical evidence, and ethical implications of oocyte cryopreservation, thereby providing a complete overview of progress in this strategy in assisted reproduction.

This thoroughly revised second edition is an up-to-date overview of the current knowledge of Notch and Notch signaling in embryology and cancer. It discusses this topic from Notch's role in the development of the embryo to the Notch signaling pathway's role in the development of a number of cancers, including breast cancer, malignant melanoma, Non-melanoma skin cancer, intestinal cancer and others. In the years since the previous edition, there have been numerous developments and insights within this rapidly moving field, making this new edition urgently needed. This volume also features discussions of current insights on Notch's role in senescence, the regulation of Notch signaling by microRNAs, Notch's role in the microbiome, diet and its influence on Notch signaling and more. Taken as a whole, with its companion books - Molecular Biology of Notch Signaling and Notch Signaling in Cancer - this is a definitive discussion of the topic, presented by internationally-recognized contributors. Presented in a coherent and accessible structure, this revised and updated second edition is an essential and up-to-date guide for oncologists, embryologists, researchers and advanced students.

An ideal reference for infertility specialists and reproductive endocrinologists alike, this comprehensive text discusses current natural and mild approaches to in vitro fertilization (IVF) and the development of in vitro maturation (IVM) as a clinical treatment. It is divided thematically into four sections. Part I presents the basic science of ovarian endocrinology and the mechanism of oocyte maturation, including follicular development and the importance of mitochondrial changes. The differences between natural cycle IVF and stimulated IVF are presented in part II, including the standard ovarian stimulation protocols and their outcomes and the etiology, prevention and management of ovarian hyperstimulation syndrome (OHSS). Minimal and mild stimulation for IVF is discussed in part III, including mild stimulation protocols for oncofertility patients and the new minimally invasive INVO procedure. In vitro maturation as a clinical treatment is the subject of part IV, discussing the methodology of immature oocyte retrieval as well as other laboratory aspects and congenital and obstetrical outcomes of babies born from IVM. Combining expertise from thought leaders around the world, Development of In Vitro Maturation for Human Oocytes will be a go-to resource for infertility researchers and practitioners and reproductive endocrinologists working with infertile couples looking for safer and more cost-effective options for treatment.

"Studies on Men s Health and Fertility "provides a comprehensive series of up-to-the-minute reviews addressing the role of oxidative stress in the aetiology of reproductive pathologies in the male. This volume represents by far the most detailed, authoritative review of the field that has been produced to date. The text encompasses the basic science of reactive oxygen species (ROS) production by mammalian spermatozoa, the way in which these highly reactive molecules are processed by the germ line and the physiological significance of this redox activity in the generation of a functional gamete. The factors responsible for perturbing the delicate balance between physiological redox signaling on the one hand and oxidative stress on the other are also extensively reviewed and some of the first clues concerning the underlying mechanisms (age, heat, infection, cryostorage, aberrant lipid metabolism), clearly identified. From a clinical perspective there are chapters setting out the methods we should be using to diagnose oxidative stress in the male germ line, a clinical perspective on the aetiology of this condition and detailed considerations of the most suitable means of ameliorating such stress from a therapeutic point of view.

"Studies on Men s Health and Fertility "is intended to provide clinicians and scientists with a snap shot of the current status of this exciting, rapidly moving field. The book will be of value to clinicians interested in strategies for the management of oxidative stress in their infertility patients and scientists wishing to understand the molecular mechanisms underpinning the generation of ROS by these cells and its pathophysiological significance. It was not so long ago that the ability of spermatozoa to generate ROS was a hotly disputed topic. With the publication of this book such doubts can finally be laid to rest. There is now no doubt that these cells actively generate ROS, that oxidative stress is a major contributor to defects in male reproductive health and that the successful clinical management of this condition depends on developing a deeper understanding of the underlying molecular mechanisms. In this quest, "Studies on Men s Health and Fertility "will be seen as a clear and important milestone. "

The first IVF conceived birth in 1978 resulted in a significant growth of third party reproductive options which continue to raise ethical, legal, and psychological questions. Third party reproduction procedures can involve as many as five people: sperm donor, egg donor, gestational carrier, and intended parents. "Third-Party Reproduction: A Comprehensive Guide" utilizes experts in the field to address the medical, psychological, ethical and legal aspects of sperm donation, egg donation, embryo donation, and the use of gestational carriers. In addition, there are chapters on the medical and ethical aspects of posthumous reproduction, religious aspects of third party reproduction, and how to avoid pitfalls of third party reproduction. Aimed at physicians, trainees, psychologists, nurses, and social workers whose practices may include patients considering third party reproduction, the intent of this book is to provide a comprehensive and practical overview of the many aspects of third party reproduction to help all those involved to better understand them. Patients considering third party reproduction may also find value in this book.

The most profound dilemma in assisted reproduction to date is the inability to recognize potentially viable embryos before their replacement into the reproductive tract. Application of increasingly advanced new technology has allowed the field of embryo evaluation to evolve rapidly and dramatically over the past five years.
Human Preimplantation Embryo Selection assembles the leaders in the field of assisted reproduction to discuss their visions of dealing with the topic of embryo selection in the light of the limitations involving the fragility of the early human embryo.
The purpose of this book is to shed light on the ever-expanding techniques that are being employed and evaluated with regard to embryo selection. A comprehensive overview may guide the ART practitioner in choice of techniques and evaluation of benefits and drawbacks.
This book will provide an up-to-date overview and reference source: an invaluable tool for assisted reproductive practice worldwide.

The aim of this book is to fill the gap between the standard textbooks of obstetrics & gynecology - which do not cover (conservative) infertility treatment - and the specialized textbooks on ART - which don't address topics such as ovulation induction/IUI and the typical treatment of disorders associated with infertility, such as hyperandrogenism and endometriosis. In many countries, the management of infertility treatment is not done by IVF specialists but by general gynecologists or primary health practitioners. In most countries, specific training and/or a license is required to do 'invasive' infertility treatments, such as IVF/ICSI; however, conservative or semi-conservative treatments - such as IUI with or without ovulation induction - can be done without specific training/licensing. This concise, clinically oriented handbook is predominantly written for gynecologists, primary health practitioners, and medical students who want to improve their knowledge on this aspect of their work. Furthermore the aim is to highlight which types of disorders may be treated by conservative means and which types of disorder should be treated by invasive treatment options such as IVF/ICSI.

In the last 15 years, fertility treatment has become mainstream medical practice. With this evolution has come a change in focus from effectiveness ('success rates') to safety, patient acceptability and ethical questions. It is recognized that effectiveness also depends crucially on safety and good risk management. The purpose of this book is to address this wider change in focus. Reducing Risk in Fertility Treatment examines risk in assisted conception, covering a wide range of topics and areas. 'Risk' refers to situations in which an outcome of value to people is uncertain. Specifically for the purpose of this book, 'Risk' means situations where patients or professionals or society as a whole is at risk of an adverse outcome in relation to fertility treatment. It therefore encompasses clinical complications, risks inherent in laboratory practice, reputational and business risks to clinics and ethical risks to society as a whole. It will be an essential resource for all clinic staff to consult in reducing the risk associated with their work. It will provide practical resources such as 'how to' guides, but also a theoretical discussion of uncertainty where this exists. The book is primarily directed to practitioners in the area of fertility treatment, namely clinicians, embryologists, nurses, counsellors and administrators. However, it is likely also to be relevant to policy-makers, commissioners of health services, researchers in this field and biomedical ethicists.